# Evaluation of TXA Prior to Surgery in the Geriatric Hip Fracture Population

> **NCT03923959** · PHASE3 · COMPLETED · sponsor: **Lancaster General Hospital** · enrollment: 283 (actual)

## Conditions studied

- Hip Fractures

## Interventions

- **DRUG:** Tranexamic Acid Injectable Solution
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03923959
- **Lead sponsor:** Lancaster General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-01
- **Primary completion:** 2022-12-09
- **Final completion:** 2022-12-09
- **Target enrollment:** 283 (ACTUAL)
- **Last updated:** 2024-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03923959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03923959, "Evaluation of TXA Prior to Surgery in the Geriatric Hip Fracture Population". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03923959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*